This is a cracking announcement, not that it will gain much traction in current market.
Pre-clinical mouse model showing greater effectiveness from AD-214 as compared to the 2 drugs currently in the market for IPF.
Still on track for mid-year first patient dosing in the phase 1 trial.
It's a happy buy and wait for me
This is a cracking announcement, not that it will gain much...
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.004(12.9%) |
Mkt cap ! $14.19M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 2.9¢ | 2.7¢ | $57.32K | 2.040M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 821147 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 30000 | 1 |
View Market Depth
| Last trade - 12.48pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
2.8¢ |
Change
-0.004 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 2.9¢ | 2.9¢ | 2.7¢ | 1166410 | ||
| Last updated 12.51pm 29/04/2024 ? | |||||
| 1AD (ASX) Chart |